Response to levosimendan predicts response to cardiac contractility modulation therapy: a pilot study
Rev Esp Cardiol (Engl Ed). 2024 Aug;77(8):703-705.
doi: 10.1016/j.rec.2024.02.012.
Epub 2024 Mar 7.
[Article in
English,
Spanish]
Affiliations
- 1 Heart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, Naples, Italy. Electronic address: [email protected].
- 2 Heart Failure Unit, Department of Cardiology, AORN dei Colli-Monaldi Hospital, Naples, Italy.
- 3 Electrophysiology Unit, Department of Cardiology, AORN dei Colli Monaldi Hospital, Naples, Italy.
- 4 Cardiology Unit, Department of Medical Translational Sciences, University of Campania "Luigi Van-Vitelli" Naples, Italy.
No abstract available
MeSH terms
-
Aged
-
Cardiotonic Agents* / pharmacology
-
Cardiotonic Agents* / therapeutic use
-
Female
-
Heart Failure* / drug therapy
-
Heart Failure* / physiopathology
-
Heart Failure* / therapy
-
Humans
-
Male
-
Middle Aged
-
Myocardial Contraction* / drug effects
-
Myocardial Contraction* / physiology
-
Pilot Projects
-
Pyridazines / therapeutic use
-
Simendan* / pharmacology
-
Simendan* / therapeutic use
-
Treatment Outcome
Substances
-
Simendan
-
Cardiotonic Agents
-
Pyridazines